Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (44)
  • 2024 (69)
  • 2023 (82)
  • 2022 (87)
  • 2021 (68)
  • 2020 (9)
  • 2019 (8)
  • 2018 (3)
  • 2017 (3)
  • 2003 (1)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (267)
  • Take Back Day (246)
  • Diversion Division (242)
  • Task Forces/Task Force Officers (230)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Other (8)
  • Campaigns (7)
  • Critical Incident (6)
  • Counterfeit Pills (5)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • One Pill Can Kill (110)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)

Drug Name

  • Fentanyl (109)
  • Opioids (58)
  • Oxycodone (50)
  • Synthetic Opioids (27)
  • Methamphetamine (20)
  • Hydromorphone (12)
  • Benzodiazepines (8)
  • Cocaine (7)
  • Morphine (7)
  • Heroin (5)
  • Methadone (4)
  • Amphetamines (3)
  • Ketamine (3)
  • Marijuana (Cannabis) (3)
  • Steroids (3)
  • GHB (1)
  • Marijuana Concentrates (1)

Field Division

  • Washington, DC (52)
  • St. Louis (36)
  • Houston (34)
  • New York (24)
  • Omaha (24)
  • Chicago (22)
  • Sede (21)
  • Miami (20)
  • El Paso (17)
  • Atlanta (16)
  • New Jersey (16)
  • Dallas (15)
  • Rocky Mountain (15)
  • Seattle (12)
  • Los Angeles (8)
  • New England (8)
  • San Diego (8)
  • Louisville (7)
  • San Francisco (7)
  • New Orleans (6)
  • Phoenix (4)
  • Philadelphia (2)
Clear All Results
PRESS RELEASE

DEA Launches Fentanyl Free America Initiative to Combat the Synthetic Drug Crisis

Diciembre 03, 2025
DALLAS – The U.S. Drug Enforcement Administration is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America, a comprehensive enforcement initiative and public awareness campaign aimed at reducing both the supply and demand for fentanyl. This effort underscores DEA's unwavering commitment to...
Diciembre 03, 2025
PRESS RELEASE

Southern New Mexico Medical Spa Operator Settles Allegations of Controlled-Substance Recordkeeping Violations

Diciembre 03, 2025
Note: View the Settlement Agreement ALBUQUERQUE – The United States has reached a civil settlement with Luis Carlos Cordova, operator of Limitless Aesthetics and Healthcare in Santa Teresa, New Mexico, to resolve allegations that he failed to meet federal controlled-substance recordkeeping requirements under the Controlled Substances Act. According to the...
Diciembre 03, 2025
PRESS RELEASE

DEA Launches Fentanyl Free America Initiative to Combat the Synthetic Drug Crisis

Diciembre 03, 2025
OMAHA – The U.S. Drug Enforcement Administration (DEA) is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America, a comprehensive enforcement initiative and public awareness campaign aimed at reducing the supply and demand for fentanyl. Through intensified enforcement operations and heightened intelligence...
Diciembre 03, 2025
PRESS RELEASE

DEA Launches Fentanyl Free America Initiative to Combat the Synthetic Drug Crisis

Diciembre 03, 2025
ST. LOUIS – The U.S. Drug Enforcement Administration (DEA) is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America, a comprehensive enforcement initiative and public awareness campaign aimed at reducing both the supply and demand for fentanyl. Through intensified enforcement operations and...
Diciembre 03, 2025
PRESS RELEASE

Digital Health Company Cofounder/CEO and Clinical President Convicted in $100M Adderall Distribution and Health Care Fraud Scheme

Noviembre 20, 2025
SAN FRANCISCO – United States Drug Enforcement Administration (“DEA”) San Francisco Division Special Agent in Charge Bob Beris, DEA New York Division Special Agent in Charge Frank Tarentino, along with our law enforcement partners Homeland Security Investigations (“HSI”) , U.S. Department of Health and Human Services – Office of Inspector...
Noviembre 20, 2025
PRESS RELEASE

DEA operation nets 628,000 Carfentanil pills in L.A. County

Noviembre 19, 2025
LOS ANGELES – An operation led by the Drug Enforcement Administration Los Angeles Field Division in October uncovered 628,000 pills containing carfentanil. According to the DEA, carfentanil is a synthetic opioid approximately 10,000 times more potent than morphine and 100 times more potent than fentanyl. The majority of the pills...
Noviembre 19, 2025
PRESS RELEASE

Digital Health Company Cofounder/CEO and Clinical President Convicted in $100M Adderall Distribution and Health Care Fraud Scheme

Noviembre 19, 2025
NEW YORK – United States Drug Enforcement Administration (“DEA”) New York Division Special Agent in Charge Frank Tarentino, DEA San Francisco Division Special Agent in Charge Robert Beris, along with our law enforcement partners Homeland Security Investigations (“HSI”) New York , U.S. Department of Health and Human Services – Office...
Noviembre 19, 2025
PRESS RELEASE

DEA Hosts the 29th National Prescription Drug Take Back Day on Saturday, October 25th

Octubre 22, 2025
SAN FRANCISCO – The Drug Enforcement Administration, in collaboration with nearly 4,000 law enforcement partners across the country, will host the 29th National Prescription Drug Take Back Day this Saturday, October 25, from 10 a.m. to 2 p.m. At nearly 4,000 collection sites throughout the United States, DEA’s National Prescription...
Octubre 22, 2025
PRESS RELEASE

Warning: Thousands of Counterfeit M30 Pills Containing Carfentanil Seized in Western Washington

Septiembre 24, 2025
SEATTLE- The Drug Enforcement Administration Seattle Field Division is warning the public after a seizure of counterfeit M30 pills containing carfentanil in Western Washington. On Tuesday, September 16th, 2025, after a months-long investigation, the Drug Enforcement Administration (DEA), Alcohol Tobacco and Firearms (ATF), Federal Way Police and Centralia Police seized...
Septiembre 24, 2025
PRESS RELEASE

Season 5 of Awkward Conversation Launches on YouTube Wednesday, September 24

Septiembre 22, 2025
WASHINGTON – The U.S. Drug Enforcement Administration, in partnership with the Benevolent and Protective Order of the Elks, will release Season 5 of the video podcast Awkward Conversations on September 24, 2025. The unscripted Season 5 of Awkward Conversations is once again hosted by Jodie Sweetin (Full House, Fuller House...
Septiembre 22, 2025
Showing 1 - 10 of 374 results

Paginación

  • Current page 1
  • Página 2
  • Página 3
  • Página 4
  • Página 5
  • Página 6
  • Página 7
  • Página 8
  • Página 9
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster